David L Corcoran
Overview
Explore the profile of David L Corcoran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
5592
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bae-Jump V, Sill M, Gehrig P, Merker J, Corcoran D, Pfefferle A, et al.
Gynecol Oncol
. 2025 Mar;
195:66-74.
PMID: 40056832
Introduction: We evaluated the efficacy of the addition of the anti-diabetic drug metformin to standard-of-care paclitaxel and carboplatin (PC) in patients with advanced and recurrent endometrial cancer (EC). Methods: In...
2.
Hoos E, Koval L, Corcoran D, Eaves L, Roell K, Rager J, et al.
Carcinogenesis
. 2025 Jan;
46(1).
PMID: 39873457
Endometrial cancer (EC) is the fourth most common cancer in women in the USA. Stark racial disparities are present in EC outcomes in which Black women have significantly higher EC-related...
3.
Conway K, Edmiston S, Vondras A, Reiner A, Corcoran D, Shen R, et al.
JCO Precis Oncol
. 2024 Nov;
8:e2400375.
PMID: 39509669
Purpose: Patients with stage II and III cutaneous primary melanoma vary considerably in their risk of melanoma-related death. We explore the ability of methylation profiling to distinguish primary melanoma methylation...
4.
Wijetunga N, Gessner K, Kanchi K, Moore J, Fleischmann Z, Jin D, et al.
Cancer Res Commun
. 2024 Aug;
4(9):2320-2334.
PMID: 39113632
Significance: Clinicogenomic analysis of radiation-associated bladder cancer uncovered mutational signatures that, in addition to a short tumor latency, smoking, and CDKN2A loss, are associated with a poor outcome. These clinical...
5.
Zhang X, Taylor H, Valdivia A, Dasari R, Buckley A, Bonacquisti E, et al.
J Control Release
. 2024 Jun;
372:433-445.
PMID: 38908756
Transdifferentiation (TD), a somatic cell reprogramming process that eliminates pluripotent intermediates, creates cells that are ideal for personalized anti-cancer therapy. Here, we provide the first evidence that extracellular vesicles (EVs)...
6.
Zhang X, Taylor H, Valdivia A, Dasari R, Buckley A, Bonacquisti E, et al.
bioRxiv
. 2024 Jun;
PMID: 38854085
Transdifferentiation (TD), a somatic cell reprogramming process that eliminates pluripotent intermediates, creates cells that are ideal for personalized anti-cancer therapy. Here, we provide the first evidence that extracellular vesicles (EVs)...
7.
Whitman E, Ryan C, Abraham W, Addae A, Corcoran D, Elliott M, et al.
Neurobiol Aging
. 2024 Feb;
136:23-33.
PMID: 38301452
Biological aging is the correlated decline of multi-organ system integrity central to the etiology of many age-related diseases. A novel epigenetic measure of biological aging, DunedinPACE, is associated with cognitive...
8.
Das J, Banskota N, Candia J, Griswold M, Orenduff M, de Cabo R, et al.
Aging Cell
. 2023 Oct;
22(12):e13963.
PMID: 37823711
The lifespan extension induced by 40% caloric restriction (CR) in rodents is accompanied by postponement of disease, preservation of function, and increased stress resistance. Whether CR elicits the same physiological...
9.
Whitman E, Ryan C, Abraham W, Addae A, Corcoran D, Elliott M, et al.
medRxiv
. 2023 Sep;
PMID: 37732266
Biological aging is the correlated decline of multi-organ system integrity central to the etiology of many age-related diseases. A novel epigenetic measure of biological aging, DunedinPACE, is associated with cognitive...
10.
Wertz J, Moffitt T, Arseneault L, Barnes J, Boivin M, Corcoran D, et al.
Nat Hum Behav
. 2023 Jun;
7(8):1388-1401.
PMID: 37386103
Genetic inheritance is not the only way parents' genes may affect children. It is also possible that parents' genes are associated with investments into children's development. We examined evidence for...